Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug612 | Blood samples (collection of 5 mL of blood in a dry tube) Wiki | 1.00 |
| drug2514 | Nasopharyngeal swabs Wiki | 0.71 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This is a pilot feasibility study of remotely delivered Problem Management Plus, a low-intensity psychological intervention, delivered in five sessions to adults affected by crisis. The current study will evaluate the feasibility and acceptability of the intervention when delivered remotely via Zoom to community members in New York City impacted by the COVID-19 pandemic. The investigator's goal is to use qualitative and quantitative approaches to inform procedures for a subsequent cluster randomized control trial of Problem Management Plus versus enhanced usual care. A mixed-methods design will be used to evaluate the feasibility, acceptability, perceived utility, and impact of the remotely delivered PM+ intervention, to determine recruitment and retention rates, to assess ethics and safety of trial procedures. Additionally, the study will evaluate the acceptability, feasibility and fidelity of the remote training and supervision of helpers trained to deliver the intervention.
Description: 4-item measure of personalized distress and client-generated problems, function and wellbeing
Measure: Psychological Outcomes Profile Time: 1 week post-interventionDescription: 9-item measure of depression symptoms
Measure: Patient Health Questionnaire Time: 1 week post-interventionDescription: 7-item measure of anxiety symptoms
Measure: Generalized Anxiety Disorder Time: 1 week post-interventionDescription: 12-item assessment of ability to engage in daily activities and functioning
Measure: World Health Organization Disability Assessment Scale Time: 1 week post-interventionDescription: 26-item quality of life assessment of physical health, psychological health, social relationships and environment
Measure: World Health Organization Quality of Life Questionnaire-BREF Time: 1 week post-interventionDescription: Health status measure of mobility, self-care, usual activities, pain and discomfort, and anxiety and depression
Measure: EuroQoL 5-dimension 5-level Time: 1 week post-interventionDescription: 19-item measure of sleep quality and disturbance
Measure: Pittsburgh Sleep Quality Index Time: 1 week post-interventionDescription: 8-item assessment of the presence and severity of common somatic symptoms
Measure: Somatic Symptom Scale Time: 1 week post-interventionDescription: 12-item measure of behavioral and psychosocial skills related to coping mechanisms
Measure: Reducing Tension Checklist for Problem Management Plus Skills Time: 1 week post-interventionDescription: 64-item measure of the impact of COVID-19 on health and wellbeing
Measure: CoRonavIruS Health Impact Survey Time: 1 week post-interventionAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports